Cargando…
NICE recommends acalabrutinib for chronic lymphocytic leukaemia
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085795/ https://www.ncbi.nlm.nih.gov/pubmed/33948080 http://dx.doi.org/10.1007/s40274-021-7683-2 |
Ejemplares similares
-
NICE COVID-19 rapid guidelines
Publicado: (2021) -
NICE consulting on methods used for health technology evaluation
Publicado: (2020) -
Acalabrutinib for mantle cell lymphoma, chronic lymphocytic leukaemia
Publicado: (2020) -
NICE to publish guidelines for rare blood clotting syndrome from COVID-19 vaccination
Publicado: (2021) -
EMA issues recommendations on impurities in medicines
Publicado: (2020)